For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

In a review of the electronic health records of more than 223,000 veterans treated at Veterans Health Administration facilities, the researchers found that even modest decreases in the normal ABI correlated with a higher risk of major adverse limb events (MALE) requiring intervention, including amputation and revascularization (treatment to restore blood flow).

The one-year professorship is administered by the American Association of Rhodes Scholars and is awarded annually to a senior scholar “of the highest distinction” from the United States.

The Vanderbilt Center for Antibody Therapeutics has received large-scale government grants and contracts to fund the discovery of human antiviral antibodies. The problem is the next step — finding corporate partners to develop the antibodies through human testing.

A multi-institutional group has identified a “signature” of metabolic molecules associated with exercise-induced physiologic deficits that, when released into the bloodstream, signal heightened heart failure risk.

Four open-heart operations later, Eden is now in second grade and bubbling with ebullient energy. To honor the lifesaving compassionate care she received at Monroe Carell, her parents established a fund in her name, as Elisa Hill put it, “to be for another family what others were for us.”